在莫桑比克扩大宫癌查:与诊断和治疗宫癌相关的挑战
Samantha Batman1, Ricardina Rangeiro2, Eliane Monteiro3
1The University of Texas MD Anderson Cancer Center, Houston, TX.
JCO global oncology
|October 12, 2023
概括
莫桑比克 莫桑比克的莫桑比克是一个国家.
科学领域:
- 在瘤学瘤学.
- 公共卫生 公共卫生
- 妇科 妇科医生 妇科
背景情况:
- 莫桑比克面临着全球高水平的子宫癌负担.
- 有限的资源和医疗保健专业人员阻碍了晚期疾病的有效治疗.
研究的目的:
- 描述被诊断患有侵袭性宫癌的妇女的结果.
- 通过与计划生育服务集成的人类乳头瘤病毒 (HPV) 测试来评估宫癌查.
主要方法:
- 在MULHER研究中30-49岁女性的预期招生.
- 初级HPV检测,然后对查阳性病例进行治疗 (热切除/切除).
- 将可疑病例转介给妇科瘤学家.
主要成果:
- 在9,014名妇女中,有30名被诊断患有子宫癌 (2020-2023年).
- 大多数人呈现出局部晚期 (60%) 或未分期 (23.3%) 的疾病.
- 观察到显著的治疗延迟和死亡率;只有18名患者接受了瘤治疗.
结论:
- 在资源较低的环境中进行子宫部查可能会增加侵袭性癌症的诊断.
- 迫切需要在莫桑比克提高获得先进的手术,放射和息治疗的机会.
相关概念视频
Cancer
48.6K
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
48.6K
Primary Healthcare Services
1.4K
Primary care promotes wellness and prevents disease. This care includes health promotion, education, protection (such as immunizations), early disease screening, and environmental considerations. Settings providing this type of healthcare include physician offices, public health clinics, school nursing, and community health nursing.
In 1978, international leaders convened in Alma-Ata, Kazakhstan, for what would be a pivotal event in global health. The Alma-Ata Declaration was the first to call...
In 1978, international leaders convened in Alma-Ata, Kazakhstan, for what would be a pivotal event in global health. The Alma-Ata Declaration was the first to call...
1.4K
Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K


